We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+13.32%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$3.25B
AUM Growth
+$41.1M
Cap. Flow
-$79.9M
Cap. Flow %
-2.46%
Top 10 Hldgs %
46.44%
Holding
100
New
9
Increased
45
Reduced
16
Closed
7

Sector Composition

Rank Sector Weight
1 Healthcare 18.02%
2 Consumer Discretionary 9.12%
3 Financials 7.36%
4 Technology 5.82%
5 Industrials 5.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTZ
51
CALL
DELISTED
Hertz Global Holdings, Inc.
HTZ
$13.4M 0.41%
841,700
-52,282
-6% -$787K
CUE icon
52
Cue Biopharma
CUE
$114M
$12.4M 0.38%
45,940
+16,670
+57% +$4.15M
SRL icon
53
Scully Royalty
SRL
$87.1M
$11.2M 0.34%
839,654
-6,901
-0.8% -$78.7K
SIGA icon
54
SIGA Technologies
SIGA
$219M
$10.2M 0.31%
1,800,514
AKBA icon
55
CALL
Akebia Therapeutics
AKBA
$252M
$9.68M 0.3%
+2,000,000
New +$11.4M
FTACU
56
DELISTED
FinTech Acquisition Corp. III Unit
FTACU
$9.03M 0.28%
+842,730
New +$8.82M
APTO
57
DELISTED
Aptose Biosciences, Inc.
APTO
$8.9M 0.27%
7,582
+7,444
+5,394% +$6.85M
GYRE icon
58
Gyre Therapeutics
GYRE
$744M
$7.69M 0.24%
139,046
+11,280
+9% +$705K
SIC
59
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
$7.61M 0.23%
653,461
+51,500
+9% +$611K
CEMI
60
DELISTED
Chembio diagnostics, Inc.
CEMI
$7.55M 0.23%
1,239,983
+89,983
+8% +$607K
RDNW
61
RideNow Group
RDNW
$262M
$7.32M 0.23%
81,718
SSKN
62
DELISTED
Strata Skin Sciences
SSKN
$7.1M 0.22%
285,100
+20,800
+8% +$519K
ELVT
63
DELISTED
Elevate Credit, Inc.
ELVT
$7.06M 0.22%
1,714,364
+150,000
+10% +$669K
HTZ
64
DELISTED
Hertz Global Holdings, Inc.
HTZ
$7.02M 0.22%
440,000
-20,400
-4% -$307K
PVLA
65
Palvella Therapeutics
PVLA
$2.27B
$6.95M 0.21%
18,470
+1,494
+9% +$446K
GLMD icon
66
Galmed Pharmaceuticals
GLMD
$4.97M
$6.56M 0.2%
4,884
+469
+11% +$605K
TLYS icon
67
Tilly's
TLYS
$128M
$6.55M 0.2%
858,103
+165,000
+24% +$1.67M
BRSL
68
CALL
Brightstar Lottery PLC
BRSL
$2.03B
$6.49M 0.2%
500,000
TA
69
DELISTED
TravelCenters of America LLC
TA
$6.03M 0.19%
333,273
+188,393
+130% +$3.61M
NEOS
70
DELISTED
Neos Therapeutics, Inc
NEOS
$5.95M 0.18%
4,610,000
+125,000
+3% +$230K
APEN
71
DELISTED
Apollo Endosurgery, Inc.
APEN
$5.88M 0.18%
1,810,562
-100,000
-5% -$356K
LINC icon
72
Lincoln Educational Services
LINC
$1.3B
$5.63M 0.17%
2,436,805
NATR icon
73
Nature's Sunshine
NATR
$288M
$5.51M 0.17%
583,510
INSUU
74
DELISTED
Insurance Acquisition Corp. Unit
INSUU
$5.17M 0.16%
500,000
SHOS
75
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
$5.08M 0.16%
2,136,251

Similar funds

Nantahala Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Nantahala Capital Management held 100 positions worth $3.25B, up 1.3% from $3.21B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Nantahala Capital Management's Q2 2019 filing shows 9 new, 45 increased, 16 reduced and 7 closed positions. Its largest new stake was Wayfair: 180,970 shares worth $26.4M. The largest sale was GTT Communications, Inc., an estimated $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Nantahala Capital Management's largest Q2 2019 buy was Wayfair: 180,970 shares worth $26.4M.
  • Nantahala Capital Management added most to RH in Q2 2019, an estimated $20.2M increase.
  • Nantahala Capital Management's biggest Q2 2019 reduction was GTT Communications, Inc., cutting an estimated $12.8M.
  • Nantahala Capital Management fully exited Ready Capital in Q2 2019, selling an estimated $9.53M.
  • Nantahala Capital Management's ten largest holdings make up 46% of its $3.25B portfolio in Q2 2019.
  • Nantahala Capital Management opened 9 new positions and closed 7 in Q2 2019.
  • Nantahala Capital Management's portfolio value rose 1.3% quarter-over-quarter to $3.25B.

Based on Nantahala Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.